InspireMD Appoints Dan Dearen to Board, Replacing Thomas Kester

InspireMD, Inc.

Thomas Kester resigned as Class III director effective Sept. 16, 2025; no disagreement cited.
Danny Lee Dearen Jr. appointed Class III director, Audit Committee chair, and Compensation Committee member.
Dearen received ~$180K equity grant (75% restricted stock, 25% stock options) vesting in one year.
Kester received accelerated vesting, extended option expiry, and ~$120K in stock/options as separation.

item 5.02item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.